Hypertension Trials in Palermo, Italy
Conditions / Hypertension / Palermo, Italy
Research into Hypertension spans multiple therapeutic approaches and trial phases.
13 total trials for this combination
Showing top 10 of 13 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07064473 | EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease | RECRUITING | — |
| NCT07181109 | Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease | RECRUITING | — |
| NCT00174304 | Open Label Study To Assess The Effectiveness Of Amlodipine-Atorvastatin Combination In Hypertension And Dyslipidemia. | COMPLETED | PHASE4 |
| NCT03626688 | A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients | COMPLETED | — |
| NCT00160160 | Comparison of Eprosartan/HCT Versus Enalapril/HCT in Hypertensives With Type II Diabetes | COMPLETED | NA |
| NCT02235909 | An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertension | COMPLETED | PHASE3 |
| NCT00549770 | Efficacy and Safety of LCZ696A in Patients With Essential Hypertension | COMPLETED | PHASE2 |
| NCT07064473 | EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease | RECRUITING | — |
| NCT03683186 | A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension | ENROLLING_BY_INVITATION | PHASE3 |
| NCT04442334 | The European NAFLD Registry | RECRUITING | — |